Category: Uncategorized

Curapath & Certest Join Forces to Offer Next-Generation Lipid Nanoparticles (LNP) Formulations with Proprietary Excipients

VALENCIA & ZARAGOZA, SPAIN, 07 OCT 2024. Curapath, a leading innovator in the manufacturing of novel lipid and polymer excipients, nanoparticle formulations and innovative polymer conjugates, and Certest Biotech, a Spanish company focused on the development of new products with special emphasis in Drug Delivery with Lipid Nanoparticles (LNPs) and Active Pharmaceutical

READ MORE »

Curapath Appoints Philippe Clavel as Chief Executive Officer

Curapath, a developer, manufacturer, and formulator of lipid- and polymer-based nanoparticles used in advanced therapeutic delivery technology, today announced the appointment of Philippe Clavel as Chief Executive Officer. Curapath is a portfolio company of Arcline Investment Management. Philippe has previously held leadership positions in the pharmaceutical and biotechnology industries. Most recently, he

READ MORE »

Curapath Receives Accreditation as a GMP Investigational Drug Product Manufacturer from the Spanish Agency for Medicine and Health Products

Valencia, Spain and Boston, MA, January 26, 2023 – Curapath, a leader in the design, development, andcustom manufacturing of polyamino-acid- and lipid nanoparticle (LNP) delivery systems for therapeuticsand vaccines, today announced the company has received accreditation as a GMP investigational drugproduct manufacturer from the Spanish Agency for Medicine and Health Products

READ MORE »

Curapath Announces Collaboration with Afrigen Biologics to Advance Development of African-owned mRNA SARS-CoV-2 Vaccine

Curapath will develop and optimize a process to produce a nanoparticle formulation for the vaccine Valencia, Spain and Boston, MA, November 16, 2022 – Curapath, a leader in the design, development, and custom manufacturing of polyamino-acid- and lipid-based nanoparticle delivery systems for therapeutics and vaccines, today announced a collaboration with

READ MORE »

Polypeptide Therapeutics Solutions (PTS) Announces Company Name Change to Curapath and Expansion of Drug Delivery Capabilities and Services

Expanded capabilities support development and production of novel functional lipid excipients and nanoparticle formulation Addition of late stage clinical and commercial-scale production is also planned Company to present on shielding lipid novel excipients for lipid nanoparticle (LNP) formulations at Lipid Nanoparticles Development Summit on October 20th Valencia, Spain and Boston,

READ MORE »

Curapath Honored By PaternaMajor and Spanish Government Innovation Delegation

PaternaMajor and the Spanish Government Innovation Delegation identified Curapath (formerly PTS), as one of the most innovative companies in the Valencian Community region. The Government delegate in the Valencian Community, Pilar Bernabe, visited the Paterna Technology Park, an area that has a number of high-tech industries, research centers and significant focus

READ MORE »

Proyecto CDTI: Investigación de una nueva vacuna para una enfermedad respiratoria humana

Hipra Scientific S.L.U, Polypeptide Therapeutic Solutions S.L., Biotechvana S.L. y Nostrum Biodiscovery constituyen el consorcio de empresas que participan en el proyecto “Investigación de una nueva vacuna para una enfermedad respiratoria humana”, subvencionado por el CDTI (Centro para el Desarrollo Tecnológico Industrial), apoyado por el Ministerio de Ciencia e Innovación

READ MORE »